经静脉导线拔除中经皮赘生物抽吸的多中心安全性与结局
结果显示完全抽吸率为75%,TLE完全成功率为92%,临床成功率为98%,抽吸相关主要并发症发生率为4%。中位随访139天时死亡率为19%,提示该策略可行且总体安全,但器械相关感染的拔除后死亡率仍较高。
要点
- 赘生物平均大小为2.8±1.8 cm,完全抽吸率为75%。
- 抽吸相关主要并发症发生率为4%,总体安全性可接受。
- 中位随访139天时死亡率为19%,辅助抽吸的获益仍需进一步研究。
核心结论
- 经静脉导线拔除中行经皮赘生物抽吸在技术上是可行的,且总体安全性较好。
- 器械相关感染拔除后的死亡率仍较高,辅助抽吸对结局的影响尚需进一步研究。
研究设计与样本
- 共抽吸63处赘生物,涉及114根导线的拔除,导线平均留置时间为9.0±8.2年。
- 患者平均年龄62±14岁,女性占28%。
主要发现
- 抽吸指征包括菌血症44例(83%)、真菌血症4例(8%)、不明原因发热1例(2%)、无菌性血栓减容4例(8%)。
- 赘生物平均大小为2.8±1.8 cm,采用经食管或心腔内超声心动图评估。
- 抽吸装置包括Penumbra Indigo(34%)、Inari FlowTriever(30%)和AngioVac(36%)。
- 完全抽吸在40例患者(75%)中实现,TLE完全成功49例(92%),临床成功52例(98%)。
- 抽吸相关主要并发症发生于2例患者(4%),中位随访139天时10例患者(19%)死亡。
关键数值与推荐
- 完全抽吸定义为赘生物经抽吸后完全清除,实现于40例患者(75%)。
- TLE完全成功率为92%,临床成功率为98%。
- 抽吸相关主要并发症发生率为4%。
临床怎么用
- 对于TLE期间存在导线相关赘生物的患者,可考虑经皮机械抽吸以降低赘生物负荷。
- 围术期需关注抽吸相关并发症,发生率约为4%。
- 拔除后仍需警惕高死亡率风险,本队列中位随访139天死亡率为19%。
局限性
- 回顾性设计存在选择偏倚,且缺乏对照组。
- 随访时间较短,中位随访仅139天,远期结局尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Background Transvenous lead extraction (TLE) for cardiac implantable electronic device infection has high procedural success, but with a 1-year mortality approaching 25%. Potential mechanisms include septic embolization and persistent infected lead casts or “ghosts.” Percutaneous mechanical aspiration of lead-related vegetations during TLE is a potential strategy to reduce vegetation burden, but safety and outcomes data are limited. Objectives To describe a multicenter experience utilizing percutaneous vegetation aspiration during TLE, including vegetation characteristics, procedural techniques, complications, and outcomes. Methods A retrospective multicenter registry included patients undergoing aspiration of lead-related masses at the time of TLE between 2016 and 2024 across six institutions. Clinical, microbiologic, and procedural data were collected. Vegetation size and outcomes were assessed using transesophageal or intracardiac echocardiography. Results Fifty-three patients (62 ± 14 years, 28% female) underwent aspiration of 63 vegetations during extraction of 114 leads (mean dwell time 9.0 ± 8.2 years). Indications included bacteremia in 44 (83%), fungemia in 4 (8%), fever of unknown origin in 1 (2%), and aseptic thrombus debulking in 4 (8%). Mean vegetation size was 2.8 ± 1.8 cm. Aspiration devices included Penumbra Indigo (34%), Inari FlowTriever (30%), and AngioVac (36%). Complete aspiration occurred in 40 patients (75%). TLE achieved complete success in 49 (92%) and clinical success in 52 (98%). Major complications related to aspiration occurred in 2 patients (4%). After a median follow-up of 139 days, 10 patients (19%) died. Conclusions Percutaneous vegetation aspiration during TLE appears feasible and generally safe. However, mortality following extraction for device-related infection remains substantial, and the impact of adjunctive aspiration on outcomes requires further study.
引用
- Journal of Cardiovascular Electrophysiology:Safety and Outcomes of Percutaneous Vegetation Aspiration During Transvenous Lead Extraction: A Multicenter Experience
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。